Radiation Oncology Market 2022 Growth, Trend, Analysis, Future Opportunities and Industry Forecast to 2030

SDKI Inc. published a new report on the radiation oncology market. This study includes the statistical and analytical approaches needed to grow the radiation oncology market. The key industry insights provided in the report provide readers with better ideas about market overviews regarding existing market scenarios. In addition, the report contains a detailed discussion of current and future market trends related to market growth.

Report sample URL
https://www.sdki.jp/sample-request-107297

The radiation oncology market is estimated to reach US $ 11.43 billion by 2030 from a market value of US $ 7.26 billion in 2022 and is expected to grow at a CAGR of 6.7% during the 2022-2030 forecast period.

Radiation oncology uses high-energy radiation such as gamma rays, X-rays, protons, and electrons to treat cancer. Is a specialist who uses. These high-energy ionizing radiation directly or indirectly damage nucleic acids through the formation of reactive oxygen species and free radicals. Radiation therapy can be used in combination with chemotherapy, surgery, and immunotherapy. The National Cancer Institute estimates that about 1.6 million new cancer cases have been diagnosed in the United States, and 595,690 died of cancer in 2016. According to a World Health Organization survey, about 14 million new cancer cases have been diagnosed and are expected to increase by about 70% over the next 20 years.

Increasing global cancer incidence, growing elderly population, and technological advances are key drivers of the growth of the radiation oncology market during the forecast period. In addition, emerging market markets are expected to grow rapidly during the forecast period. This is due to increased medical costs, increased patient pools, and increased public awareness of medical care. However, the high cost of equipment and treatment, side effects, and the shortage of trained technicians in developing countries could curb the growth of the radiation oncology market between 2022 and 2030.

Radiation Oncology Market Segment

The radiation oncology market is available by type of treatment (external beam radiation therapy, internal beam radiation therapy, and systemic radiation therapy) and application (prostatic cancer, cervical cancer, breast cancer, lung cancer, head and neck cancer, brain cancer, etc.). It is divided by end user (hospital, radiation therapy center, outpatient service center, etc.) and by region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

Report sample URL

https://www.sdki.jp/sample-request-107297

Based on the type of treatment, the radiation oncology market is divided into external beam radiation therapy, internal beam radiation therapy, and systemic radiation therapy. In 2017, the external beam radiotherapy segment had the largest share. Due to its ease of use, it is a highly effective treatment for various types of cancer, including prostate cancer, which can cure up to 95% of cases. External beam radiation therapy is further subdivided by technology and product. Technologies include IGRT, IMRT, VMAT, SBRT, SRS, IMPT and more.

Regional Overview of the Radiation Oncology Market The

North American region is expected to become a major region of the radiation oncology market. High medical costs, advanced medical infrastructure, and significant R & D investment are some of the key factors contributing to the region's dominance in the radiation oncology market. In addition, the presence of key players such as Varian Medical Systems, Accuray Incorporated and Nordion Inc. is expected to drive the growth of the radiation oncology market.

These regional segments are North America (US and Canada); Asia Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Singapore, Other Asia Pacific); Latin America (Brazil, Mexico, Argentina, etc.) Latin America); Middle East and Africa (Israel, GCC [Saudi Arabia, Arab Emirates, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, and other Middle East and Africa) and Europe (UK, Germany, France, Italy) , Spain, Hungary, Belgium, Netherlands, Luxemburg, NORDIC, Poland, Turkey, Russia and other Europe) and more.

Details of the survey report

https://www.sdki.jp/press-details/global-radiation-oncology-market/313

Key Players in the Radiation Oncology Market

Key players in the Radiation Oncology Market include Accuray Incorporated, Elekta AB, Varian Medical Systems, and CR. Bard, Inc., IBA Worldwide, Carl Zeiss Meditec AG, Mevion Medical Systems, Nordion, Inc., IsoRay, Inc., Hitachi Medical Corporation, ViewRay, Inc. and more. The study includes a detailed competitive analysis of these major companies in the radiation oncology market, corporate profiles, recent developments, and key market strategies.

Contact Us

Hina Miyazu
15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc. Company Profile

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.